Demand Gen Report's 2026 survey shows 50% of companies now use a single source of truth as data unification is replacing ...

Hims & Hers is quietly building a healthcare platform, aiming to control the primary interface for diagnostics, prevention, and personalized treatments. Learn more.

As Gianakakos, Chief Medical Officer Edelberg and the rest of the Kardigan team continue developing their pipeline through ...

Transaction positions Nuwellis to expand into real-time kidney function monitoring and strengthen its long-term cardiorenal platform, subject to customary closing conditions ...

Nearly two decades after the Council of Yukon First Nations first released a report calling for a cancer strategy, the Yukon ...

First-party data is, as the kids say, having a moment. The concept resurfaced in the public consciousness when Google postponed its anticipated phase-out of third-party cookies on Chrome until 2024.

Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on advancing precision cardiorenal care in critical care settings, today announced that ...

Georgetown officials are developing an urban forest master plan to preserve and plant trees in the city as well as create guidelines for tree planting to ensure they grow. The det ...

Mobile CrowdSensing (MCS) has become a powerful sensing paradigm for information collection recently. As sensing becomes more ...

Central Banking’s regtech and suptech interviews are in‑depth exploration of the pioneering work at central banks and ...

The transition to an AI-native enterprise is a fundamental architectural shift. For leaders at late-stage startups, the path to scale involves five key actions.

Explore Barron’s 2026 Roundtable “dogcatcher” dividend picks—74 stocks, top 10 up 22.45% by Jan 2027, with NLY & RCI flagged as safer. Read more macro analysis here.